HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eileen Francis

Reporter – US

Eileen Francis is a reporter for “The Tan Sheet,” where she follows news on OTC drug and nutritional product manufacturing, regulation, legislation, finance and research. She previously served as a reporter and editor of “The Rose Sheet,” IBI’s source for in-depth coverage of the cosmetics industry. Early in her career, Eileen worked in public relations and as a writer for a lobbying firm. Outside of IBI, her freelance work includes articles on business, art and travel.

Latest From Eileen Francis

Kyowa Hakko Expands Probiotic Supplies With ‘Dead’ Ingredient To Battle Eye Fatigue

Kyowa Hakko unveils supplement ingredient Eyemuse, a heat-treated “parabiotic” found to reduce eye fatigue, filter blue light and support a balanced immune response. CRN campaign educates retailers, consumers about probiotics and helps retailers improve handling of the products.

Dietary Supplements Ingredients

No Pandemic Hangover Expected For Health, Beauty Launches At Independent Pharmacies

Wellness products accounted for the highest number of launches among health, wellness and beauty products at independent pharmacies in 2020. But the overall number slumped 21.1% due to the pandemic, according to Hamacher Resource Group’s report on a product rating system.

Market Intelligence Launches

Funding For US FDA Work On Cannabinoids Regulatory Pathway Drives Progress Only So Far

FDA is conducting lab testing on CBD products with funding in its FY2021 appropriations, says senior agency advisor Sharon Mayl. Some work planned work in the area has been delayed by the agency's response to COVID-19.

Cannabidiol CBD FDA

Legislating US Regulatory Pathway For Cannabinoids ‘Not End of The World’ – Gottlieb

Former FDA commissioner says legislative carve-out for a regulatory pathway for cannabinoids is a better option than a rulemaking, which could take five years and “may not even work.” Cannabinoids market is “well far ahead of where the regulation is,” he says.

Cannabidiol CBD FDA

BASF Settles With US FTC About False Fatty Liver Claims For Hepaxa Omega-3 Supplements

German multi-national and a former US distributor agreed to pay more than $416,000 to US FTD for unsupported claims about omega-3 supplements for adults and children. In complaint, FTC alleged the firms “cherry picked” data from supporting human studies to fit claims.

VITAL Ancillary Study Results Cast More Doubt On Cardio Benefit From Omega-3, Vitamin D

AF events occurred in 469 (3.7%) of subjects receiving EPA and DHA supplements compared to 431 (3.4%) of participants receiving placebos. In vitamin D3 and placebo comparison, AF events occurred in 469 (3.7%) versus 431 (3.4%).

Dietary Supplements Ingredients
See All
UsernamePublicRestriction

Register